Novo, Lilly drop on uncertainty over Medicare GLP-1 plan
Summary
Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock slip as health insurers remain undecided on a U.S. program to expand coverage for GLP-1 obesity drugs. Read m...
Description
Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock slip as health insurers remain undecided on a U.S. program to expand coverage for GLP-1 obesity drugs. Read m...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source